Long-term Iron Absorption and Losses in Young South African Women Living Without and With Overweight and Obesity

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Young women living with obesity (OB) have a greater risk of developing iron deficiency. Plus, the risk of anemia and/or ID in young women living with overweight (OW) and obesity (OB) is further increased by inadequate dietary intake and/or poor bioavailability of iron, as well as gastrointestinal and menstrual iron losses. It is not certain whether women living with OW/OB can meet their iron requirements from their day-to-day diet. The aim of this study is to compare iron absorption and losses over a long period between women living with and without OW and OB. Secondary outcomes include iron and inflammation status, as well as dietary iron intake.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 35
Healthy Volunteers: t
View:

• Of African descent

• BMI of 18.5 to 24.9 kg/m2 for participants living without OW/OB and BMI ≥ 28 kg/m2 for participants living with OW/OB

• Having low to moderate inflammation-adjusted iron stores (ferritin ≤50 µg/L)

• Absence of low-grade inflammation (CRP\<2 mg/l) for participants living without OW/OB and presence of low-grade inflammation CRP 2-20 mg/l) for participants living with OW/OB

• Planning to reside in the study area for at least 2 years

Locations
Other Locations
South Africa
Esté Vorster Research Facility
RECRUITING
Potchefstroom
Contact Information
Primary
Mary Uyoga, PhD
44645104@mynwu.ac.za
+27 18 299 4237
Backup
Linda Malan, PhD
Linda.Malan@nwu.ac.za
+27 18 299 4237
Time Frame
Start Date: 2025-07-24
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 70
Treatments
Active_comparator: Living without overweight/obesity
Participants with body mass index between 18 and 24.9 kg/m2
Experimental: Living with overweight/obesity
Participants with body mass index equal to or greater than 28 kg/m2
Related Therapeutic Areas
Sponsors
Collaborators: ETH Zurich (Switzerland), King's College London
Leads: Linda Malan

This content was sourced from clinicaltrials.gov